Anzeige
Mehr »
Montag, 16.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
20 Leser
Artikel bewerten:
(0)

Vaccine Adjuvants Market Overview, Top Manufacturers With Sales, Revenue and Industry Share Forecast to 2022, Says a New Research at ReportsnReports

PUNE, India, August 29, 2017 /PRNewswire/ --

An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.

Browse 172 Tables and Figures, spread across 121 pages is available at http://www.reportsnreports.com/reports/941413-global-vaccine-adjuvants-market-by-manufacturers-countries-type-and-application-forecast-to-2022.html .

Vaccine Adjuvants Market reports present the revenue opportunities in the Vaccine Adjuvants industry through 2022, highlighting the market size and growth by technology, geography, and sector and size band. This report analyses the current market trends, drivers and inhibitors impacting the Vaccine Adjuvants Market. The report displays the competitive situation among the top manufacturers, with sales; revenue and market share in 2016 and 2017. This report focuses on the Vaccine Adjuvants in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers - SEPPIC, SDA BIO, Brenntag Biosector, SPI Pharma, MVP Laboratories, Tj Kaiwei, Novavax, Zhuoyue, Aphios, GSK, CSL Limited, and Avanti Polar Lipids

Market Segment by Type, covers: Oral, Subcutaneous, Intramuscular, Others and Market Segment by Applications, can be divided into Adjuvants in each application, can be divided into, Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications), and Human Vaccine Adjuvants (Research Applications, Commercial Applications).

Order a Copy of Report at http://www.reportsnreports.com/purchase.aspx?name=941413 .

There are 15 Chapters to deeply display the global Vaccine Adjuvants market.

Chapter 1, Describe Vaccine Adjuvants Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, Analyse the top manufacturers of Vaccine Adjuvants, with sales, revenue, and price of Vaccine Adjuvants, in 2016 and 2017; Chapter 3, Display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, Show the global market by regions, with sales, revenue and market share of Vaccine Adjuvants, for each region, from 2012 to 2017; Chapter 5, 6, 7 and 8, analysed the key regions, with sales, revenue and market share by key countries in these regions; Chapter 9 and 10, Shows the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

In Chapter 11, Vaccine Adjuvants market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022; Chapter 12 and 13, Described Vaccine Adjuvants sales channel, distributors, traders, dealers, appendix and data source.

Related Reports topic 'Global Medical Cyclotron Market by Manufacturers, Countries, Type and Application, Forecast to 2022' report forecasts the market analysis provided for the Global markets including development trends, competitive landscape analysis, and key regions development status. With 200 tables and figures and 119 pages the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market. There are 15 Chapters to deeply display the global Medical Cyclotron market. This report focuses on the Medical Cyclotron in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

About Us:

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports. We provide 24/7 online and offline support to our customers.

Contact:
Hrishikesh Patwardhan
2nd Floor, Metropole,
Next to Inox Theatre,
Bund Garden Road,
Pune - 411001
Maharashtra,India.
+1-888-391-5441
sales@reportsandreports.com

Connect With Us On:
LinkedIn: www.linkedin.com/company/reportsnreports
RSS:http://www.reportsnreports.com/feed/p-219-global-info-research.xml


© 2017 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.